ITEM 1.02 TERMINATION OF A MATERIAL DEFINITIVE AGREEMENT
On October 16, 2009, Palomar Medical Technologies, Inc. (the "Company"), a Delaware corporation, announced the termination of its Joint Development and License Agreement with Johnson & Johnson Consumer Companies Inc ("JJCC"), a Johnson & Johnson company, to develop, clinically test and commercialize home-use, light-based devices for (i) reducing or reshaping body fat including cellulite; (ii) reducing appearance of skin aging; and (iii) reducing or preventing acne. On Tuesday, October 13, 2009, JJCC notified the Company that it was terminating the Joint Development and License Agreement effective as of such date. The Company's press release announcing the termination of this agreement is entitled "Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson" and is filed as Exhibit 99.1 to this Current Report on Form 8-K.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(d) Exhibits

Number Title 99.1 Press Release issued by Palomar Medical Technologies, Inc. on October 16, 2009